TissueScan, Drosophila Normal cDNA Array

SKU
DSRT101
12 samples covering Drosophila normal and embryonic tissues. Available in 2, 5, 10 identical plates.
  $370.00
2 Weeks*
Specifications
Specifications
Product Data
TissueScan Type Normal Tissue
Array Name Drosophila Normal cDNA Array
Diagnosis Category Normal
Tissue Multiple
Shipping Ambient
Description 12 samples covering Drosophila normal and embryonic tissues. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

The EEF1A2 gene expression as risk predictor in localized prostate cancer
Worst, Waldbillig, Abdelhadi et al
BMC Urol (2017) 17 (1), 86 DOI: 10.1186/s12894-017-0278-3
Cited by 25
AI Summary: In this study, OriGene products including the EEF1A2-specific siRNA (SR300366) and the EEF1A2 qRT-PCR primer set (HP208849) were used to assess the expression and functional role of EEF1A2 in prostate cancer tissues and cell lines, contributing to the finding that EEF1A2 overexpression is linked to higher tumor stage and poorer prognosis.
FigureFigureFigure
Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells
Kuroda, Yasuda, Nakashima et al
Sci Rep (2017) 7 (1), 8163 DOI: 10.1038/s41598-017-08014-w
AI Summary: OriGene’s TissueScan™ Cancer Survey Panel 4 × 96-III cDNA array was used to analyze TNNT1 mRNA expression across multiple cancer and normal tissue samples, supporting the identification of TNNT1 as a marker for immortalized retinal pigment epithelial cells.
Snippet: TissueScan Cancer and Normal Tissue cDNA Array Analysis. The TissueScan Cancer Survey Panel 4 × 96-III (Origene) was used according to the manufacturer's protocol. The panel consisted of 381 cDNA samples covering 18 different cancers. ...;;... TissueScan Cancer and Normal Tissue cDNA Array Analysis. The TissueScan Cancer Survey Panel 4 × 96-III (Origene) was used according to the manufacturer's ...
FigureFigureFigure
TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1
Wang, Liu, Qiu et al
Oncogenesis (2017) 6 (4), e323 DOI: 10.1038/oncsis.2017.18
AI Summary: OriGene’s TissueScan Cancer and Normal Tissue cDNA Arrays were used in this study to quantitatively analyze TCRP1 gene expression across various human cancer and normal tissue samples.
Snippet: To examine the gene expression levels for TCRP1 in different cancer patient tissue samples, we performed quantitative PCR analysis on TissueScan Cancer and Normal Tissue cDNA Arrays (Origene Company, Rockville, MD, USA), which include 392 cases from different ... All 3 versions Cite SaveSaving
The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense
Itahana, Han, Barbier et al
Oncogene (2014)
Cited by 102
AI Summary: OriGene’s Tissue Scan Cancer and Normal Tissue cDNA arrays were used to measure SLC2A9 mRNA expression in various cancer and normal tissues, enabling the authors to analyze the relationship between SLC2A9 levels and cancer prognosis.
Snippet: We measured SLC2A9 mRNA expression in a variety of cancer and normal tissues (Origene Technologies) by real-time PCR. ... Tissue Scan Cancer and Normal Tissue cDNA array were purchased from Origene (Rockvile, MD, USA) to examine the expression of SLC2A9 ... Cite SaveSaving
Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection
Abujarour, Valamehr, Robinson et al
Sci Rep (2013) 3, 1179 DOI: 10.1038/srep01179
Cited by 58
AI Summary: OriGene’s TissueScan™ Normal Tissue cDNA Array was used in this study to analyze gene expression in normal tissue samples via qPCR, supporting the evaluation of surface marker specificity for hiPSC selection.
Snippet: Tables 1 and 2. For the analysis of gene expression in normal tissue samples (n = 48), TissueScan Normal Tissue cDNA Array (OriGene Technologies) was used in the qPCR analyses. The heat map was generated using the DataAssist software (Life Technologies).
FigureFigureFigure
Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent
Annabi, Lord-Dufour, Vézina et al
Drug Target Insights (2012) 6, 1-11 DOI: 10.4137/DTI.S9442
Cited by 3
AI Summary: OriGene’s TissueScan™ cancer and normal tissue cDNA arrays were used in this study to analyze differential Sirt1 gene expression across various stages of brain cancer.
Snippet: TissueScan cancer and normal tissue cDNA arrays were purchased from OriGene (Rockville, MD), covered 43 clinical samples of the brain cancer four stages and normal tissues, and were used to analyze differential Sirt1 gene expression according to the manufacturer's
FigureFigureFigure
Showing 1-6 of 9 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products